US EditionPublished • loading... • Updated
Some Blood Pressure Pills Recalled for Possible Contamination
- On Dec. 1, the U.S. Food and Drug Administration warned of a nationwide recall covering roughly 11,100 bottles of Ziac, Glenmark Pharmaceuticals’ bisoprolol fumarate‑hydrochlorothiazide product.
- Reserve-Sample testing revealed trace amounts of ezetimibe at the manufacturer's facility in Madhya Pradesh, India, and Glenmark Pharmaceuticals also produces this cholesterol drug.
- The FDA listed specific affected lots and bottle counts, noting 30-count bottles , 11,100 100- and 500-count bottles with expirations from November 2025 to May 2026, and doses of 2.5-mg and 6.25-mg.
- Patients are urged to check packaging and contact their pharmacy or prescriber, while neither Glenmark Pharmaceuticals nor the U.S. Food and Drug Administration immediately responded to requests for comment.
- Clinically, the drug combo bisoprolol fumarate and hydrochlorothiazide is commonly prescribed to lower blood pressure and reduce heart attack and stroke risk, and the recall is Class III, meaning exposure is unlikely to cause adverse health consequences.
Insights by Ground AI
30 Articles
30 Articles
The Independent+2 Reposted by 2 other sources
Blood pressure medication recalled over fears of cross-contamination with other drug
Samples of the pill ‘showed presence’ of another type of drug, the FDA said
·London, United Kingdom
Read Full Article
FDA Recalls Blood Pressure Medication Due to Contamination
The U.S. Food and Drug Administration (FDA) has issued a recall for blood pressure medication after finding cross contamination with a drug used to treat high cholesterol. The post FDA Recalls Blood Pressure Medication Due to Contamination appeared first on Breitbart.
·United States
Read Full Article
The Norfolk Daily News+17 Reposted by 17 other sources
Some Blood Pressure Pills Recalled for Possible Contamination
Key Takeaways
Coverage Details
Total News Sources30
Leaning Left7Leaning Right3Center7Last UpdatedBias Distribution41% Left, 41% Center
Bias Distribution
- 41% of the sources lean Left, 41% of the sources are Center
41% Center
L 41%
C 41%
R 18%
Factuality
To view factuality data please Upgrade to Premium
